Risks of Solid and Lymphoid Malignancies in Patients with Myeloproliferative Neoplasms: Clinical Implications
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risks of Solid and Lymphoid Malignancies in Patients with Myeloproliferative Neoplasms: Clinical Implications
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 10, Pages 3061
Publisher
MDPI AG
Online
2020-10-21
DOI
10.3390/cancers12103061
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sa2019 – Chemoprevention of Colorectal Cancer in the General Population: An Umbrella Metaanalysis
- (2019) Marc Bardou et al. GASTROENTEROLOGY
- Clinical outcomes under hydroxyurea treatment in polycythemia vera: a systematic review and meta-analysis
- (2019) Alberto Ferrari et al. HAEMATOLOGICA
- Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study
- (2019) Tiziano Barbui et al. LEUKEMIA
- Prevalence of Colorectal Neoplasms and Mortality in New Users of Low-Dose Aspirin With Lower Gastrointestinal Bleeding
- (2019) Frederikke S. Troelsen et al. AMERICAN JOURNAL OF THERAPEUTICS
- Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population
- (2019) Sabrina Cordua et al. BLOOD
- Reply to: Second primary malignancies in myeloproliferative neoplasms and the role of aspirin
- (2019) Tiziano Barbui et al. LEUKEMIA
- Vascular Diseases In Patients With Chronic Myeloproliferative Neoplasms – Impact Of Comorbidity
- (2019) Henrik Frederiksen et al. Clinical Epidemiology
- Second cancers in MPN: Survival analysis from an international study
- (2019) Monia Marchetti et al. AMERICAN JOURNAL OF HEMATOLOGY
- Smoking, blood cells and myeloproliferative neoplasms: meta‐analysis and Mendelian randomization of 2·3 million people
- (2019) Nimesh A. Jayasuriya et al. BRITISH JOURNAL OF HAEMATOLOGY
- Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy
- (2018) Edit Porpaczy et al. BLOOD
- Second malignancies in patients with myeloproliferative neoplasms: a population-based cohort study of 9379 patients
- (2018) Anna Ravn Landtblom et al. LEUKEMIA
- Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
- (2018) Tiziano Barbui et al. LEUKEMIA
- Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden
- (2018) Subhayan Chattopadhyay et al. Lancet Haematology
- Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma
- (2018) François Lemonnier et al. BLOOD
- Classification and Personalized Prognosis in Myeloproliferative Neoplasms
- (2018) Jacob Grinfeld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anxiety and depression in patients with Philadelphia-negative myeloproliferative neoplasms: a nationwide population-based survey in Denmark
- (2018) Nana Brochmann et al. Clinical Epidemiology
- Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia
- (2017) Cristina Santoro et al. Cancer Medicine
- Second malignancies in hydroxyurea and interferon-treated Philadelphia-negative myeloproliferative neoplasms
- (2016) Iben Onsberg Hansen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Risk and Cause of Death in Patients Diagnosed With Myeloproliferative Neoplasms in Sweden Between 1973 and 2005: A Population-Based Study
- (2015) Malin Hultcrantz et al. JOURNAL OF CLINICAL ONCOLOGY
- A population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER database
- (2015) Andrew M. Brunner et al. LEUKEMIA & LYMPHOMA
- Risk of second primary malignancies and survival of adult patients with polycythemia vera: A United States population-based retrospective study
- (2015) Nabin Khanal et al. LEUKEMIA & LYMPHOMA
- Secondary solid tumors and lymphoma in patients with essential thrombocythemia and polycythemia vera – single center experience
- (2015) Lucia Masarova et al. LEUKEMIA & LYMPHOMA
- MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives
- (2015) Hans Carl Hasselbalch et al. MEDIATORS OF INFLAMMATION
- Survival of patients with chronic myeloproliferative neoplasms and new primary cancers: a population-based cohort study
- (2015) Henrik Frederiksen et al. Lancet Haematology
- Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
- (2014) A. Tefferi et al. BLOOD
- Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis
- (2014) Helna Pettersson et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Risk of second cancers in chronic myeloproliferative neoplasms
- (2012) M. C. Susini et al. BLOOD
- Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer?
- (2012) H. C. Hasselbalch BLOOD
- Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study
- (2012) Malin Hultcrantz et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic myeloproliferative neoplasms and subsequent cancer risk: a Danish population-based cohort study
- (2011) H. Frederiksen et al. BLOOD
- Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-
- (2011) C. H. Riley et al. BLOOD
- Higher risk of primary cancers after polycythaemia vera and vice versa
- (2011) Mahdi Fallah et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms
- (2010) N. H. Thoennissen et al. BLOOD
- The JAK2 V617F somatic mutation, mortality and cancer risk in the general population
- (2010) C. Nielsen et al. HAEMATOLOGICA
- Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients
- (2010) E. Rumi et al. HAEMATOLOGICA
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Increased Risk of Lymphoid Neoplasms in Patients with Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
- (2009) A. M. Vannucchi et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- The Hazards of Hazard Ratios
- (2009) Miguel A. Hernán EPIDEMIOLOGY
- Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution
- (2008) Franca Radaelli et al. Hematology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started